Genotoxicity associated with hydroxyurea exposure in infants with sickle cell anemia: Results from the BABY-HUG phase III clinical trial

National Institutes of Health Consensus Development Conference Statement: Hydroxyurea Treatment for Sickle Cell Disease

(2013) Otis W. Brawley   ANNALS OF INTERNAL MEDICINE

Systematic Review: Hydroxyurea for the Treatment of Adults with Sickle Cell Disease

(2013) Sophie Lanzkron et al.   ANNALS OF INTERNAL MEDICINE

Chromosome damage and repair in children with sickle cell anaemia and long-term hydroxycarbamide exposure

(2011) Patrick T. McGann et al.   BRITISH JOURNAL OF HAEMATOLOGY

Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG)

(2011) Winfred C Wang et al.   LANCET

How I use hydroxyurea to treat young patients with sickle cell anemia

(2010) R. E. Ware   BLOOD

Assessment of genotoxicity associated with hydroxyurea therapy in children with sickle cell anemia

(2010) Jonathan M. Flanagan et al.   MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS

The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS)

(2009) E. Voskaridou et al.   BLOOD

Advances in the use of hydroxyurea

(2009) R. E. Ware et al.   Hematology-American Society of Hematology Education Program

Hydroxyurea for Sickle Cell Disease: A Systematic Review for Efficacy and Toxicity in Children

(2008) J. J. Strouse et al.   PEDIATRICS

DNA damage in blood leukocytes of individuals with sickle cell disease treated with hydroxyurea

(2007) João Ricardo Friedrisch et al.   MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS